Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) Long Term Investor Investigation
An investigation on behalf of current long-term stockholders of shares of Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) was announced concerning whether certain Imprimis Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.
View full press release